BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,704 | -14.4% | 71,660 | +3.3% | 0.00% | -33.3% |
| Q2 2023 | $3,159 | -31.6% | 69,348 | -39.1% | 0.00% | -25.0% |
| Q1 2023 | $4,617 | +2057.5% | 113,842 | +2611.2% | 0.00% | – |
| Q4 2022 | $214 | -99.8% | 4,199 | +291.3% | 0.00% | – |
| Q4 2021 | $92,000 | -61.7% | 1,073 | -63.7% | 0.00% | – |
| Q3 2021 | $240,000 | -55.8% | 2,954 | -56.3% | 0.00% | -100.0% |
| Q2 2021 | $543,000 | – | 6,754 | -71.8% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 23,974 | +323.6% | 0.00% | -100.0% |
| Q4 2020 | $454,000 | +108.3% | 5,659 | +108.1% | 0.00% | – |
| Q3 2020 | $218,000 | -83.6% | 2,720 | -82.4% | 0.00% | -100.0% |
| Q2 2020 | $1,330,000 | +56.3% | 15,451 | +47.4% | 0.00% | 0.0% |
| Q1 2020 | $851,000 | +1602.0% | 10,485 | +1647.5% | 0.00% | – |
| Q4 2019 | $50,000 | -69.7% | 600 | -78.0% | 0.00% | -100.0% |
| Q2 2017 | $165,000 | -79.4% | 2,730 | -84.9% | 0.01% | -85.4% |
| Q4 2016 | $802,000 | +3387.0% | 18,107 | +3521.4% | 0.05% | +2300.0% |
| Q3 2016 | $23,000 | -96.4% | 500 | -96.8% | 0.00% | -96.1% |
| Q1 2016 | $646,000 | +92.8% | 15,731 | +78.8% | 0.05% | +96.2% |
| Q4 2015 | $335,000 | -6.2% | 8,800 | -19.1% | 0.03% | 0.0% |
| Q3 2015 | $357,000 | -53.0% | 10,880 | -2.0% | 0.03% | -70.5% |
| Q1 2015 | $760,000 | – | 11,098 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |